Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Trump Endorses 'Right to Try' Experimental Drug Bill at State of the Union Address January 30, 2018 Medizone To Host Investor Conference Call September 17, 2017 Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives January 14, 2018
